Hong Kong Baptist University and Elsevier Report Charts Global Growth of Chinese Medicine Research, Calls for Standardised Frameworks for Broader Integration
HKBU and Elsevier launched a new report 'Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine', highlighting the growing global impact of Chinese Medicine research in diversified healthcare solutions.
ISTANBUL, TURKEY – Media OutReach Newswire – 17 June 2025 – The report 'Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine' released today by Hong Kong Baptist University (HKBU) and Elsevier, reveals the growing impact of Chinese Medicine research on global healthcare and modern health challenges. In this context, 'Chinese Medicine research' encompasses not only clinical practice, but also basic and translational science, AI-driven systems medicine, and the network pharmacology of herbal formulas. This first bibliometric analysis of Chinese Medicine research from 2014 to 2023 highlights the field's rapid growth, interdisciplinarity, and societal impact on Digital Health and Systems Medicine.
Key findings from the report include:
Rapid expansion : Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023.
: Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023. High scholarly impact : 14.2% of Chinese Medicine papers ranked among the world's top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12.
: 14.2% of Chinese Medicine papers ranked among the world's top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12. Interdisciplinary breadth : Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science.
: Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science. Global collaboration hubs : Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications.
: Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications. Emerging research foci : Top-published trending topics include 'Herbaceous Agent | Chinese Medicine | Network Pharmacology' and COVID-19 applications, reflecting integration of omics, AI and systems methods.
: Top-published trending topics include 'Herbaceous Agent | Chinese Medicine | Network Pharmacology' and COVID-19 applications, reflecting integration of omics, AI and systems methods. Societal resonance: 11.1% of research outputs were mentioned on social media and 2.9% cited in policy documents, reflecting growing public and policymaker interest.
Bridging a global integration gap
ADVERTISEMENT
Chinese Medicine's mainstream integration lacks a global, transparent, evidence-based framework. To elevate its scientific profile, key strategies include developing internationally accepted clinical guidelines through expert consensus, enhancing trial reporting standards to improve research quality, and fostering interdisciplinary, cross-regional collaboration to drive innovation and systemic impact.
''Evolving Legacy' demonstrates how Chinese Medicine research has matured into a global, evidence-informed field,' said Professor Lyu Aiping, Vice-President (Research & Development), HKBU, and a leading expert in Chinese Medicine. 'We envision a future where data science and AI illuminate what Chinese Medicine research has long intimated, providing deeper insights into health classifications and compound interventions. The next frontier is using Chinese Medicine research to uncover insights possibly overlooked in Digital Health and Systems Medicine, strengthening their scientific foundation and impact.'
'This report offers unprecedented insights into Chinese Medicine's evolving scientific landscape,' added Basak Candemir, Business Development Director, Analytical and Data Services, Elsevier. 'It illuminates the growing global impact of Chinese Medicine research and its role in diversified healthcare solutions, making a vital step towards bridging traditional knowledge with modern validation for the benefit of global health.'
The report was developed using Elsevier's bibliometric tools, Scopus and SciVal, based on a comprehensive dataset and case studies compiled in collaboration with HKBU Chinese Medicine research experts. The report can be accessed on https://cm-evaluation.scm.hkbu.edu.hk/.
Hashtag: #HKBU
The issuer is solely responsible for the content of this announcement.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sharjah 24
10 hours ago
- Sharjah 24
AUS engineering graduate progs reaffirmed with CAA accreditation
The CAA is responsible for licensing higher education institutions and evaluating their academic programs for accreditation. It works with both international and local authorities to safeguard academic standards and enhance the learning experience for students in higher education institutions. The 10 programs that received renewed accreditation include the master of science degrees in biomedical engineering, chemical engineering, civil engineering, construction management, computer engineering, electrical engineering, engineering systems management, mechanical engineering and mechatronics engineering, as well as the PhD in Engineering - Engineering Systems Management. The renewed accreditation comes at a time of significant advancement for graduate engineering education at AUS, marked by the launch of CEN 2.0 Graduate—a comprehensive enhancement of all graduate programs within the college. This new framework introduces coursework-only tracks across all master's programs, providing students with the flexibility to choose between thesis and non-thesis options. To accommodate working professionals, classes are offered in the evenings and on weekends. Core and elective courses have also been updated to reflect global trends and market demand, with an emphasis on areas such as artificial intelligence, digital transformation and sustainability. Dr. Fadi Aloul, Dean of CEN, said: 'This renewed accreditation affirms the strength and strategic direction of our graduate programs and their alignment with national development priorities and global innovation trends. It reflects the trust placed in AUS as a hub for advanced engineering education and research excellence. Through our rigorous academic frameworks and industry-relevant curricula, we are preparing future leaders who will shape the technologies, infrastructure and sustainable solutions of tomorrow.' CEN will further expand its graduate offerings with the introduction of two new doctoral programmes in Fall 2025—one in civil and environmental engineering and another in electrical and computer engineering—strengthening the college's interdisciplinary and research-driven approach. The college is home to a vibrant community of over 2,700 students—of which 350 are graduate students—from 70 nationalities. Twenty-one members of CEN's faculty were recently named among the world's top 2 percent of scientists by the latest Stanford-Elsevier ranking. The college also recently announced several new partnerships with top engineering schools, enabling its students to experience a world-class graduate education. AUS ranks second in the UAE for employer reputation (QS World University Rankings, 2025), and CEN's graduates regularly go on to work for leading companies such as Google, Microsoft, Amazon, Schneider Electric, Petrofac, PWC, EY, the UAE Cabinet, the UAE Space Agency and the Mohammed Bin Rashid Space Centre. Applications are open for Fall 2025 for all CEN graduate programs. All applicants are encouraged to apply for graduate assistantships. These are awarded on a competitive basis and provide students with both financial support and hands-on experience in teaching and research.
Arabian Post
10 hours ago
- Arabian Post
Hong Kong Baptist University and Elsevier Report Charts Global Growth of Chinese Medicine Research, Calls for Standardised Frameworks for Broader Integration
HKBU and Elsevier launched a new report 'Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine', highlighting the growing global impact of Chinese Medicine research in diversified healthcare solutions. ISTANBUL, TURKEY – Media OutReach Newswire – 17 June 2025 – The report 'Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine' released today by Hong Kong Baptist University (HKBU) and Elsevier, reveals the growing impact of Chinese Medicine research on global healthcare and modern health challenges. In this context, 'Chinese Medicine research' encompasses not only clinical practice, but also basic and translational science, AI-driven systems medicine, and the network pharmacology of herbal formulas. This first bibliometric analysis of Chinese Medicine research from 2014 to 2023 highlights the field's rapid growth, interdisciplinarity, and societal impact on Digital Health and Systems Medicine. Key findings from the report include: Rapid expansion : Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023. : Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023. High scholarly impact : 14.2% of Chinese Medicine papers ranked among the world's top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12. : 14.2% of Chinese Medicine papers ranked among the world's top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12. Interdisciplinary breadth : Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science. : Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science. Global collaboration hubs : Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications. : Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications. Emerging research foci : Top-published trending topics include 'Herbaceous Agent | Chinese Medicine | Network Pharmacology' and COVID-19 applications, reflecting integration of omics, AI and systems methods. : Top-published trending topics include 'Herbaceous Agent | Chinese Medicine | Network Pharmacology' and COVID-19 applications, reflecting integration of omics, AI and systems methods. Societal resonance: 11.1% of research outputs were mentioned on social media and 2.9% cited in policy documents, reflecting growing public and policymaker interest. Bridging a global integration gap ADVERTISEMENT Chinese Medicine's mainstream integration lacks a global, transparent, evidence-based framework. To elevate its scientific profile, key strategies include developing internationally accepted clinical guidelines through expert consensus, enhancing trial reporting standards to improve research quality, and fostering interdisciplinary, cross-regional collaboration to drive innovation and systemic impact. ''Evolving Legacy' demonstrates how Chinese Medicine research has matured into a global, evidence-informed field,' said Professor Lyu Aiping, Vice-President (Research & Development), HKBU, and a leading expert in Chinese Medicine. 'We envision a future where data science and AI illuminate what Chinese Medicine research has long intimated, providing deeper insights into health classifications and compound interventions. The next frontier is using Chinese Medicine research to uncover insights possibly overlooked in Digital Health and Systems Medicine, strengthening their scientific foundation and impact.' 'This report offers unprecedented insights into Chinese Medicine's evolving scientific landscape,' added Basak Candemir, Business Development Director, Analytical and Data Services, Elsevier. 'It illuminates the growing global impact of Chinese Medicine research and its role in diversified healthcare solutions, making a vital step towards bridging traditional knowledge with modern validation for the benefit of global health.' The report was developed using Elsevier's bibliometric tools, Scopus and SciVal, based on a comprehensive dataset and case studies compiled in collaboration with HKBU Chinese Medicine research experts. The report can be accessed on Hashtag: #HKBU The issuer is solely responsible for the content of this announcement.
Zawya
11 hours ago
- Zawya
Hong Kong Baptist University and Elsevier Report Charts Global Growth of Chinese Medicine Research, Calls for Standardised Frameworks for Broader Integration
ISTANBUL, TURKEY - Media OutReach Newswire - 17 June 2025 – The report "Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine" released today by Hong Kong Baptist University (HKBU) and Elsevier, reveals the growing impact of Chinese Medicine research on global healthcare and modern health challenges. In this context, "Chinese Medicine research" encompasses not only clinical practice, but also basic and translational science, AI-driven systems medicine, and the network pharmacology of herbal formulas. This first bibliometric analysis of Chinese Medicine research from 2014 to 2023 highlights the field's rapid growth, interdisciplinarity, and societal impact on Digital Health and Systems Medicine. Key findings from the report include: Rapid expansion: Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023. High scholarly impact: 14.2% of Chinese Medicine papers ranked among the world's top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12. Interdisciplinary breadth: Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science. Global collaboration hubs: Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications. Emerging research foci: Top-published trending topics include "Herbaceous Agent | Chinese Medicine | Network Pharmacology" and COVID-19 applications, reflecting integration of omics, AI and systems methods. Societal resonance: 11.1% of research outputs were mentioned on social media and 2.9% cited in policy documents, reflecting growing public and policymaker interest. Bridging a global integration gap Chinese Medicine's mainstream integration lacks a global, transparent, evidence-based framework. To elevate its scientific profile, key strategies include developing internationally accepted clinical guidelines through expert consensus, enhancing trial reporting standards to improve research quality, and fostering interdisciplinary, cross-regional collaboration to drive innovation and systemic impact. "'Evolving Legacy' demonstrates how Chinese Medicine research has matured into a global, evidence-informed field," said Professor Lyu Aiping, Vice-President (Research & Development), HKBU, and a leading expert in Chinese Medicine."We envision a future where data science and AI illuminate what Chinese Medicine research has long intimated, providing deeper insights into health classifications and compound interventions. The next frontier is using Chinese Medicine research to uncover insights possibly overlooked in Digital Health and Systems Medicine, strengthening their scientific foundation and impact." "This report offers unprecedented insights into Chinese Medicine's evolving scientific landscape," added Basak Candemir, Business Development Director, Analytical and Data Services, Elsevier. "It illuminates the growing global impact of Chinese Medicine research and its role in diversified healthcare solutions, making a vital step towards bridging traditional knowledge with modern validation for the benefit of global health." The report was developed using Elsevier's bibliometric tools, Scopus and SciVal, based on a comprehensive dataset and case studies compiled in collaboration with HKBU Chinese Medicine research experts. The report can be accessed on Hashtag: #HKBU The issuer is solely responsible for the content of this announcement. Hong Kong Baptist University
